{"status":"success","message":"Record found.","DataElement":{"publicId":"3440328","version":"1","longName":"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","shortName":"3440198v1.0:3440295v1.0","definition":"Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","context":"NCIP","origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"changeDescription":"3/1/22 jk Designated, added CDS alt name and CSI.  --- Created and released for TCGA per approval by T.Lichtenberg. mc 4/23/12","administrativeNotes":"10/29/24 per Henry/CodeMap task, add alt table LS;12/31/23 Added CDS Imaging CSI. jk;  1/20/23 Removed general CDS CSI, added CDS|Diagnosis CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"SOKKERL","dateModified":"2024-10-29","DataElementConcept":{"publicId":"3440198","version":"1","longName":"Neoplasm Clinical T Stage","shortName":"2404687v1.0:2207100v1.0","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"changeDescription":"Created for and approved by TCGA per T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"SBR","dateModified":"2016-06-06","ObjectClass":{"publicId":"2404687","version":"1","longName":"Neoplasm","shortName":"C3262","definition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","context":"NCIP","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]},"Property":{"publicId":"2207100","version":"1","longName":"Clinical T Stage","shortName":"C25398:C25728","definition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","Concepts":[{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"}]},"ConceptualDomain":{"publicId":"2008537","version":"1","longName":"Diagnosis","shortName":"DX","definition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","context":"CTEP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29"}},"ValueDomain":{"publicId":"3440295","version":"1","longName":"American Joint Committee on Cancer Clinical T Stage","shortName":"3440295v1.0","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","context":"NCIP","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":"2","maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":null,"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"changeDescription":"Created for and approved by TCGA per T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"SOKKERL","dateModified":"2024-02-08","PermissibleValues":[{"value":"T0","valueDescription":"T0 Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201423","version":"1","longName":"T0 Stage Finding","shortName":"3201423","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"ONEDATA","dateModified":"2011-03-08","Concepts":[{"longName":"T0 TNM Finding","conceptCode":"C48719","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1","valueDescription":"T1 Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201424","version":"1","longName":"T1 Stage Finding","shortName":"3201424","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.\r\n","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1a","valueDescription":"T1a Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201425","version":"1","longName":"T1a Stage Finding","shortName":"3201425","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T1a TNM Finding","conceptCode":"C48721","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1a1","valueDescription":"Stage T1a1 Finding","origin":null,"beginDate":"2011-08-16","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3151369","version":"1","longName":"Stage T1a1 Finding","shortName":"3151369","definition":"A pathologic primary tumor TNM stage finding.  The definition of pT1a stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1a stage finding is defined as follows: cancer with tumor size more than 0.1 cm, but not more than 0.5 cm in greatest dimension; for lung cancer, pT1a stage finding is defined as follows: cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"pT1a TNM Finding","conceptCode":"C48760","definition":"A pathologic primary tumor TNM finding.  The definition of pT1a finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1a finding is defined as follows: cancer with tumor size more than 0.1 cm, but not more than 0.5 cm in greatest dimension; for lung cancer, pT1a finding is defined as follows: cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1a2","valueDescription":"Stage T1a2 Finding","origin":null,"beginDate":"2011-08-16","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3151371","version":"1","longName":"Stage T1a2 Finding","shortName":"3151371","definition":"Invasive cervical cancer with measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Cervical Cancer pT1a2 TNM Finding v7","conceptCode":"C89529","definition":"Invasive cervical cancer with measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1b","valueDescription":"T1b Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201426","version":"1","longName":"T1b Stage Finding","shortName":"3201426","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T1b TNM Finding","conceptCode":"C48722","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1b1","valueDescription":"T1b1 Stage Finding","origin":null,"beginDate":"2012-01-03","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3151375","version":"1","longName":"T1b1 Stage Finding","shortName":"3151375","definition":"Cervical cancer with clinically visible lesion 4.0 cm or less in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Cervical Cancer pT1b1 TNM Finding v7","conceptCode":"C89533","definition":"Cervical cancer with clinically visible lesion 4.0 cm or less in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1b2","valueDescription":"T1b2 Stage Finding","origin":null,"beginDate":"2012-01-03","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3151377","version":"1","longName":"T1b2 Stage Finding","shortName":"3151377","definition":"Invasive cervical cancer with clinically visible lesion more than 4.0 cm in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Cervical Cancer pT1b2 TNM Finding v7","conceptCode":"C89534","definition":"Invasive cervical cancer with clinically visible lesion more than 4.0 cm in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1c","valueDescription":"T1c Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201427","version":"1","longName":"T1c Stage Finding","shortName":"3201427","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T1c TNM Finding","conceptCode":"C48723","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T1mi","valueDescription":"T1mi Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201428","version":"1","longName":"T1mi Stage Finding","shortName":"3201428","definition":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T1mi TNM Finding","conceptCode":"C95805","definition":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2","valueDescription":"T2 Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201429","version":"1","longName":"T2 Stage Finding","shortName":"3201429","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2a","valueDescription":"T2a Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201430","version":"1","longName":"T2a Stage Finding","shortName":"3201430","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T2a TNM Finding","conceptCode":"C48725","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2a1","valueDescription":"Stage T2a1 Finding","origin":null,"beginDate":"2011-08-16","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3151383","version":"1","longName":"Stage T2a1 Finding","shortName":"3151383","definition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions 4.0 cm or less in greatest dimension are present.  (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Cervical Cancer pT2a1 TNM Finding v7","conceptCode":"C89537","definition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions 4.0 cm or less in greatest dimension are present.  (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2a2","valueDescription":"Stage T2a2 Finding","origin":null,"beginDate":"2011-08-16","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3151385","version":"1","longName":"Stage T2a2 Finding","shortName":"3151385","definition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions more than 4.0 cm in greatest dimension are present.  (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Cervical Cancer pT2a2 TNM Finding v7","conceptCode":"C89538","definition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions more than 4.0 cm in greatest dimension are present.  (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2b","valueDescription":"T2b Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201431","version":"1","longName":"T2b Stage Finding","shortName":"3201431","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and  is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T2b TNM Finding","conceptCode":"C48726","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2c","valueDescription":"T2c Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201432","version":"1","longName":"T2c Stage Finding","shortName":"3201432","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T2c TNM Finding","conceptCode":"C48727","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T3","valueDescription":"T3 Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201433","version":"1","longName":"T3 Stage Finding","shortName":"3201433","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.\r\n","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T3a","valueDescription":"T3a Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201434","version":"1","longName":"T3a Stage Finding","shortName":"3201434","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota's fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T3a TNM Finding","conceptCode":"C48729","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota's fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T3b","valueDescription":"T3b Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201435","version":"1","longName":"T3b Stage Finding","shortName":"3201435","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T3b TNM Finding","conceptCode":"C48730","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T3c","valueDescription":"T3c Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201436","version":"1","longName":"T3c Stage Finding","shortName":"3201436","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3c TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava above the diaphragm, or invades the wall of the vena cava; for fallopian tube cancer it refers to a primary tumor with peritoneal metastasis outside the pelvis measuring more than 2 cm in diameter; for melanoma of the conjunctiva it refers to a primary tumor invading the orbit.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T3c TNM Finding","conceptCode":"C48731","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3c TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava above the diaphragm, or invades the wall of the vena cava; for fallopian tube cancer it refers to a primary tumor with peritoneal metastasis outside the pelvis measuring more than 2 cm in diameter; for melanoma of the conjunctiva it refers to a primary tumor invading the orbit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T4","valueDescription":"T4 Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201437","version":"1","longName":"T4 Stage Finding","shortName":"3201437","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.\r\n","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T4a","valueDescription":"T4a Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201438","version":"1","longName":"T4a Stage Finding","shortName":"3201438","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T4a TNM Finding","conceptCode":"C48733","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T4b","valueDescription":"T4b Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201439","version":"1","longName":"T4b Stage Finding","shortName":"3201439","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T4b TNM Finding","conceptCode":"C48734","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T4c","valueDescription":"T4c Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201440","version":"1","longName":"T4c Stage Finding","shortName":"3201440","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T4c TNM Finding","conceptCode":"C48735","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T4d","valueDescription":"T4d Stage Finding","origin":null,"beginDate":"2010-04-01","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201441","version":"1","longName":"T4d Stage Finding","shortName":"3201441","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T4d TNM Finding","conceptCode":"C48736","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"Ta","valueDescription":"Ta Stage Finding","origin":null,"beginDate":"2011-03-18","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3205588","version":"1","longName":"Ta Stage Finding","shortName":"3205588","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive papillary carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"Tis","valueDescription":"Tis Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201442","version":"1","longName":"Breast Cancer pTis TNM Finding v6 and v7","shortName":"3201442v1.00","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"Tis (DCIS)","valueDescription":"Tis Stage Finding Ductal Breast Carcinoma In Situ","origin":null,"beginDate":"2011-03-08","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201554","version":"1","longName":"Tis Stage Finding Ductal Breast Carcinoma In Situ","shortName":"3201554","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"ONEDATA","dateModified":"2011-03-10","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"}]}},{"value":"Tis (LCIS)","valueDescription":"Tis Stage Finding Lobular Breast Carcinoma In Situ","origin":null,"beginDate":"2011-03-08","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201555","version":"1","longName":"Tis Stage Finding Lobular Breast Carcinoma In Situ","shortName":"3201555","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.: A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"}]}},{"value":"Tis (Paget's)","valueDescription":"Tis Stage Finding Paget Disease of the Breast without Invasive Carcinoma","origin":null,"beginDate":"2011-03-08","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201556","version":"1","longName":"Tis Stage Finding Paget Disease of the Breast without Invasive Carcinoma","shortName":"3201556","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.: Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Breast Paget Disease without Invasive Carcinoma","conceptCode":"C47858","definition":"Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"}]}},{"value":"TX","valueDescription":"TX Stage Finding","origin":null,"beginDate":"2010-03-31","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","ValueMeaning":{"publicId":"3201443","version":"1","longName":"TX Stage Finding","shortName":"3201443","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T2d","valueDescription":"T2d Stage Finding","origin":null,"beginDate":"2015-10-21","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"ONEDATA","dateModified":"2015-10-21","ValueMeaning":{"publicId":"5037553","version":"1","longName":"T2d Stage Finding","shortName":"5037553","definition":"Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2015-10-21","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Melanoma of the Ciliary Body and Choroid pT2d TNM Finding v7","conceptCode":"C88695","definition":"Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T4e","valueDescription":"T4e Stage Finding","origin":null,"beginDate":"2015-10-21","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"ONEDATA","dateModified":"2015-10-21","ValueMeaning":{"publicId":"5037554","version":"1","longName":"T4e Stage Finding","shortName":"5037554","definition":"Any tumor size category with extraocular extension more than 5 mm in diameter. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2015-10-21","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Melanoma of the Ciliary Body and Choroid pT4e TNM Finding v7","conceptCode":"C88706","definition":"Any tumor size category with extraocular extension more than 5 mm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T3d","valueDescription":"T3d Stage Finding","origin":null,"beginDate":"2015-10-21","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"ONEDATA","dateModified":"2015-10-21","ValueMeaning":{"publicId":"5037555","version":"1","longName":"T3d Stage Finding","shortName":"5037555","definition":"Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2015-10-21","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"Melanoma of the Ciliary Body and Choroid pT3d TNM Finding v7","conceptCode":"C88700","definition":"Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"T5","valueDescription":"T5 Stage Finding","origin":null,"beginDate":"2016-12-19","endDate":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","ValueMeaning":{"publicId":"5608187","version":"1","longName":"T5 Stage Finding","shortName":"5608187","definition":"An antiquated primary tumor finding term that refers to colorectal cancer which has spread by direct extension beyond the immediately adjacent organs or tissues. (AJCC 1st Ed.)","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","Concepts":[{"longName":"T5 TNM Finding","conceptCode":"C132010","definition":"An antiquated primary tumor finding term that refers to colorectal cancer which has spread by direct extension beyond the immediately adjacent organs or tissues. (AJCC 1st Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"Unknown","valueDescription":null,"origin":null,"beginDate":"2024-02-08","endDate":null,"deletedIndicator":"No","createdBy":"SOKKERL","dateCreated":"2024-02-08","modifiedBy":"SOKKERL","dateModified":"2024-02-08","ValueMeaning":{"publicId":"5682953","version":"1","longName":"Unknown","shortName":"5682953","definition":"Not known, not observed, not recorded, or refused.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"changeDescription":null,"administrativeNotes":"3/4/25 Added alt VM names per RFC 26 CR 1. sl","unresolvedIssues":null,"deletedIndicator":"No","createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"SLAUER","dateModified":"2025-03-04","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}},{"value":"Not Reported","valueDescription":null,"origin":null,"beginDate":"2024-02-08","endDate":null,"deletedIndicator":"No","createdBy":"SOKKERL","dateCreated":"2024-02-08","modifiedBy":"SOKKERL","dateModified":"2024-02-08","ValueMeaning":{"publicId":"5612322","version":"1","longName":"Not Reported","shortName":"5612322v1.00","definition":"Not provided or available.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"changeDescription":null,"administrativeNotes":"3/4/25 Added alt VM names per RFC 26 CR 1. sl;\r\n10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No","createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"SLAUER","dateModified":"2025-03-04","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}]}}],"ConceptualDomain":{"publicId":"2008549","version":"1","longName":"Involvement and Extent of Disease","shortName":"INV_AND_EXT_OF_DZ","definition":"indication of the presence and extent of disease.","context":"CTEP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29"},"RepresentationTerm":{"publicId":"3440299","version":"1","longName":"American Joint Committee on Cancer Clinical T Stage Stage","shortName":"C39315:C25398:C25728:C16899","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","context":"NCIP","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No","createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"}]}},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"CCDI (Childhood Cancer Data Initiative)","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594093","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596043","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596241","version":"1","longName":"Diagnosis","context":"Pediatric Cancer"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]},{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"12177497","version":"1","longName":"Diagnosis","context":"CRDC"},{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"clinical_T","type":"TCGA_XML_Name","context":"NCIP"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"OTH_TUMOR_C_T_STG","type":"COG GDE Short Name","context":"COG"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"3440198v1.0:3440295v1.0","type":"USED_BY","context":"DCP"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"CRDC","type":"USED_BY","context":"CRDC"},{"name":"tumor_stage_clinical_t","type":"CDS Alt Name","context":"CRDC"},{"name":"tumor_stage_clinical_t","type":"CCDI Alt Name","context":"Pediatric Cancer"},{"name":"diagnosis","type":"CCDI Table","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"documentName":"Clinical T Stage","documentText":"Clinical T Stage","documentType":"Preferred Question Text","url":null,"context":"NCIP"},{"documentName":"Generic CDE for TCGA","documentText":"This generic element includes T stage values from multiple editions of AJCC as provided by The Cancer Genome Atlas (TCGA).","documentType":"NOTE","url":null,"context":"NCIP"},{"documentName":"COG CRF Text 1","documentText":"TNM Staging: Clinical T Stage","documentType":"Alternate Question Text","url":null,"context":"COG"},{"documentName":"Clinical T Stage","documentText":"Clinical T Stage","documentType":"Alternate Question Text","url":null,"context":"DCP"}]}}